← Back to Search

Telehealth Technology for Asthma Management

N/A

Waitlist Available

Led By Chris Carlsten, M.D.

Research Sponsored by University of British Columbia

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Must have moderate or severe asthma

Must be capable to communicate in English or French

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at the end of year 3 through year four of the intervention

Awards & highlights

Study Summary

This trial will assess the effectiveness of an electronic asthma action plan (eAAP) on mobile devices, compared to a written asthma action plan (wAAP), on asthma outcomes in a Canada-wide study.

Who is the study for?

This trial is for adults with moderate or severe asthma who have had at least one exacerbation in the past year, are on both reliever and controller medications, and can use a digital device with internet. They must be able to communicate in English or French but cannot participate if they have COPD.Check my eligibility

What is being tested?

The CANATEXTS study tests whether a Telehealth intervention using an electronic asthma action plan (eAAP) via mobile devices, along with educational content and weekly reminders, can reduce asthma exacerbations over 12 months compared to standard written AAPs.See study design

What are the potential side effects?

Since this trial involves non-medical interventions like text messaging and electronic plans rather than drugs, typical medication side effects are not expected. However, participants may experience issues related to technology use.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have moderate or severe asthma.

Select...

I can communicate in English or French.

Select...

I am prescribed both quick-relief and long-term asthma medications.

Select...

I had at least one worsening of my condition in the last year.

Select...

I have been diagnosed with asthma.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at the end of year 3 through year four of the intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at the end of year 3 through year four of the intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and at the end of year 3 through year four of the intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Exacerbation

Secondary outcome measures

Asthma control

Medication adherence

Other outcome measures

Cost effectiveness

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention groupExperimental Treatment1 Intervention

Intervention group/telehealth Arm: will be provided access to their electronic asthma action plan (eAAP) via a web Uniform Resource Locator (URL), receive weekly short message service (SMS) check-ins for one year, and be able to communicate with the site's research coordinator (RC) and Certified Respiratory Educator (CRE) via an integrated and interactive (two-way) SMS feature to manage their asthma

Group II: Control groupActive Control1 Intervention

Control group/standard care Arm: will receive their written Asthma Action Plan (wAAP) and information on how to use it by the site's Certified Respiratory Educator to manage their asthma

0 / 5Eligibility criteria met

Find a Location

Who is running the clinical trial?

Vancouver Coastal Health Research InstituteOTHER

26 Previous Clinical Trials

4,570 Total Patients Enrolled

University of British ColumbiaLead Sponsor

1,415 Previous Clinical Trials

2,466,396 Total Patients Enrolled

16 Trials studying Asthma

3,176 Patients Enrolled for Asthma

Chris Carlsten, M.D.Principal InvestigatorUniversity of British Columbia

Media Library

CANATEXTS Clinical Trial Eligibility Overview. Trial Name: NCT05484037 — N/A

Asthma Research Study Groups: Intervention group, Control group

Asthma Clinical Trial 2023: CANATEXTS Highlights & Side Effects. Trial Name: NCT05484037 — N/A

CANATEXTS 2023 Treatment Timeline for Medical Study. Trial Name: NCT05484037 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants aged 50 and above eligible to join this trial?

"To be considered for enrollment, patients must fall between 19 and 80 years of age."

Answered by AI

Is there an ongoing recruitment process for this experiment?

"Clinicaltrials.gov shows that this trial, first posted on March 1st 2023, is no longer recruiting participants. However, 639 other medical studies are currently enrolling patients for their respective trials."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Application of Telehealth Technology in Asthma Management

Christopher Carlsten 2023. "Application of Telehealth Technology in Asthma Management". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05484037.